menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

Actelion Ltd (ALIOF)
278.5 0 (0%)  11-06 15:52
Open: 0 Prev Close: 278.5
High: 0 Low: 0
Volume: 0 Market Cap: 29478M
Year High: 286.3 Year Low: 0
Stock Technical Analysis
Overall       
Targets Six months: 325.7085    One year: 380.4275
Supports Support1: 277.1111   Support2: 276.0300
Resistances Resistance1: 278.8600    Resistance2: 325.7085 
Pivot Point 278.5000 
Moving Averages MA(5): 278.5000      MA(20): 278.5000 

MA(100): 278.2227  1     MA(250): 271.4613 
MACD MACD(12,26): 0.149      Signal(12,26,9): 0.188 
Stochastic Oscillator %K(14,3):       %D(3):  
RSI RSI(14): 62.451 
52-Week High: 286.3000  Low: 205.0000  Change(%): 48
Average Volume(K) 3-Month: 2  10-Days: 0
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed Bollinger Bands are 100% narrower than normal.The narrow width of the bands suggests low volatility as compared to ALIOF's normal range. The bands have been in this narrow range for 14 bars. This is often a sign that a market may be about to initiate a new trend.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Johnson & Johnson Completes Acquisition of Actelion
Fri, 16 Jun 2017 04:52:30 GMT

Actelion, J&J Are Back in Exclusive Talks a Week After Breakup
Wed, 21 Dec 2016 18:44:13 GMT

Actelion announces excellent financial results for 2016
Tue, 14 Feb 2017 06:00:00 GMT

J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal
Thu, 26 Jan 2017 06:49:29 GMT

Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD
Thu, 08 Jun 2017 05:03:45 GMT

Sanofi Backtracked on Actelion Offer Price Amid J&J Talks
Thu, 16 Feb 2017 12:56:15 GMT

J&J, Actelion Said to Reach Tentative Agreement on Price
Wed, 11 Jan 2017 21:20:22 GMT

Actelion issues invitation to 2017 Annual General Meeting of Shareholders
Wed, 15 Mar 2017 06:00:00 GMT

Sanofi reportedly in talks to buy Actelion Pharmaceuticals after Johnson ...
Wed, 14 Dec 2016 04:30:00 GMT

Actelion announces results of the MAESTRO study with macitentan in patients ...
Mon, 23 Jan 2017 06:00:00 GMT